OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)
Irina Kislaya, Paulo Gonçalves, Verónica Gómez, et al.
Infectious Diseases (2022) Vol. 54, Iss. 6, pp. 418-424
Closed Access | Times Cited: 15
Irina Kislaya, Paulo Gonçalves, Verónica Gómez, et al.
Infectious Diseases (2022) Vol. 54, Iss. 6, pp. 418-424
Closed Access | Times Cited: 15
Showing 15 citing articles:
Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal
Irina Kislaya, Pedro Casaca, Vítor Borges, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 3, pp. 569-575
Open Access | Times Cited: 13
Irina Kislaya, Pedro Casaca, Vítor Borges, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 3, pp. 569-575
Open Access | Times Cited: 13
Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy
Stefania Paduano, Pasquale Galante, Nausicaa Berselli, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 7882-7882
Open Access | Times Cited: 12
Stefania Paduano, Pasquale Galante, Nausicaa Berselli, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 13, pp. 7882-7882
Open Access | Times Cited: 12
Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April–June 2022
Irina Kislaya, Aryse Martins Melo, Marta Barreto, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 3, pp. 590-594
Open Access | Times Cited: 7
Irina Kislaya, Aryse Martins Melo, Marta Barreto, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 3, pp. 590-594
Open Access | Times Cited: 7
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children
Annabel Powell, Georgina Ireland, Rebecca Leeson, et al.
Journal of Infection (2023) Vol. 86, Iss. 4, pp. 361-368
Open Access | Times Cited: 7
Annabel Powell, Georgina Ireland, Rebecca Leeson, et al.
Journal of Infection (2023) Vol. 86, Iss. 4, pp. 361-368
Open Access | Times Cited: 7
Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey
Lara E. Coelho, Paula M. Luz, Débora Castanheira, et al.
The Lancet Regional Health - Americas (2022) Vol. 15, pp. 100338-100338
Open Access | Times Cited: 11
Lara E. Coelho, Paula M. Luz, Débora Castanheira, et al.
The Lancet Regional Health - Americas (2022) Vol. 15, pp. 100338-100338
Open Access | Times Cited: 11
Long-term neurological complications in COVID-19 survivors: study protocol of a prospective cohort study (NeurodegCoV-19)
Natália Araújo, Isa Silva, Patrícia Campos, et al.
BMJ Open (2023) Vol. 13, Iss. 7, pp. e072981-e072981
Open Access | Times Cited: 5
Natália Araújo, Isa Silva, Patrícia Campos, et al.
BMJ Open (2023) Vol. 13, Iss. 7, pp. e072981-e072981
Open Access | Times Cited: 5
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses
Yi-Chan Lin, David H. Evans, Ninette F. Robbins, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 7
Yi-Chan Lin, David H. Evans, Ninette F. Robbins, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 7
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico
Ana Basto‐Abreu, Martha Carnalla, Leticia Torres‐Ibarra, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 3
Ana Basto‐Abreu, Martha Carnalla, Leticia Torres‐Ibarra, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 3
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
Kento T. Abe, Bhavisha Rathod, Karen Colwill, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Kento T. Abe, Bhavisha Rathod, Karen Colwill, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Comparative COVID-19 Vaccines Effectiveness in Preventing Infections, Hospitalizations, and Deaths with SARS-CoV-2 BA.5 and Ba.2 Omicron Lineages: A Case-Case and Cohort Study Using Electronic Health Records in Portugal
Irina Kislaya, Pedro Casaca, Vítor Borges, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 5
Irina Kislaya, Pedro Casaca, Vítor Borges, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 5
SARS-CoV-2 Seroprevalence Following a Large-Scale Vaccination Campaign in Portugal: Results of the National Serological Survey, September - November 2021
Irina Kislaya, Paulo Gonçalves, Sara Ramalhete, et al.
Acta Médica Portuguesa (2022) Vol. 36, Iss. 1, pp. 5-14
Open Access | Times Cited: 5
Irina Kislaya, Paulo Gonçalves, Sara Ramalhete, et al.
Acta Médica Portuguesa (2022) Vol. 36, Iss. 1, pp. 5-14
Open Access | Times Cited: 5
Serological screening in a large-scale municipal survey in Cascais, Portugal, during the first waves of the COVID-19 pandemic: lessons for future pandemic preparedness efforts
Sofia G. Seabra, Francisco Merca, Bernardo de Andrada Pereira, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Sofia G. Seabra, Francisco Merca, Bernardo de Andrada Pereira, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
SARS-CoV-2 Seroprevalence in Those Utilizing Public Transportation or Working in the Transportation Industry: A Rapid Review
Aliisa Heiskanen, Yannick Galipeau, Marc‐André Langlois, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 18, pp. 11629-11629
Open Access | Times Cited: 3
Aliisa Heiskanen, Yannick Galipeau, Marc‐André Langlois, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 18, pp. 11629-11629
Open Access | Times Cited: 3
High SARS-CoV-2 seroprevalence in blood donors from Romania after the third COVID-19 pandemic wave
Tudor Rareș Olariu, Rodica Lighezan, Sorin Ursoniu, et al.
Infectious Diseases (2022) Vol. 54, Iss. 7, pp. 534-537
Open Access | Times Cited: 2
Tudor Rareș Olariu, Rodica Lighezan, Sorin Ursoniu, et al.
Infectious Diseases (2022) Vol. 54, Iss. 7, pp. 534-537
Open Access | Times Cited: 2
National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021
Annabel Powell, Georgina Ireland, Rebecca Leeson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Annabel Powell, Georgina Ireland, Rebecca Leeson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
